Brexpiprazole (Rexulti) for Agitation in Alzheimer's Dementia

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2023年 / 65卷 / 1679期
关键词：
VASOMOTOR SYMPTOMS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：10
相关论文
共 50 条
  • [21] AVP-786 for the treatment of agitation in dementia of the Alzheimer's type
    Garay, Ricardo P.
    Grossberg, George T.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (01) : 121 - 132
  • [22] EFFECTS OF BREXPIPRAZOLE ON SEVERITY OF AGITATION IN ALZHEIMER'S DEMENTIA: AN ANALYSIS OF CLINICAL GLOBAL IMPRESSION DATA FROM TWO, PHASE III FIXED-DOSE TRIALS
    Lee, D.
    Slomkowski, M.
    Hefting, N.
    Chen, D.
    Larsen, K.
    Kohegyi, E.
    Hobart, M.
    Shah, A.
    Estilo, A.
    Panni, M.
    Faerovik, A.
    Miguelez, M.
    Such, P.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 179 - 179
  • [23] Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia
    Muehlbauer, Viktoria
    Moehler, Ralph
    Dichter, Martin N.
    Zuidema, Sytse U.
    Koepke, Sascha
    Luijendijk, Hendrika J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (12):
  • [24] Agitation in Alzheimer's Dementia: Conceptual Framework to Demonstrate the Burden of Illness
    Grossberg, George T.
    Han, Xue
    Talon, Brian
    Boller, Emily
    Zhang, Wenjie
    Keeping, Sam
    INTERNATIONAL PSYCHOGERIATRICS, 2024, 36 : 102 - 102
  • [25] Assessment of agitation in Alzheimer's disease: The agitated behavior in dementia scale
    Logsdon, RG
    Teri, L
    Weiner, MF
    Gibbons, LE
    Raskind, M
    Peskind, E
    Grundman, M
    Koss, E
    Thomas, RG
    Thal, LJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (11) : 1354 - 1358
  • [26] Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse models (vol 44, pg 557,2024)
    Amada, N.
    Sato, S.
    Ishikawa, D.
    Nakamura, M.
    Suzuki, M.
    Futamura, T.
    Maeda, K.
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (04) : 868 - 868
  • [27] An overview of the pathophysiology of agitation in Alzheimer's dementia with a focus on neurotransmitters and circuits
    Cummings, Jeffrey L.
    Brubaker, Malaak
    Selzler, Katherine J.
    Gonzalez, Sarah T.
    Patel, Mehul
    Stahl, Stephen M.
    CNS SPECTRUMS, 2024, 29 (05) : 316 - 325
  • [28] EFFICACY, SAFETY AND TOLERABILITY OF BREXPIPRAZOLE FOR THE TREATMENT OF AGITATION IN ALZHEIMER'S DEMENTIA: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Grossberg, George
    Lee, Daniel
    Slomkowski, Mary
    Hefting, Nanco
    Chen, Dalei
    Larsen, Groes
    Kohegyi, Eva
    Hobart, Mary
    Cummings, Jeffrey
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S99 - S100
  • [29] Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials
    Marinheiro, Gabriel
    Dantas, Julyana Medeiros
    Mutarelli, Antonio
    de Almeida, Artur Menegaz
    Monteiro, Gabriel de Almeida
    Zerlotto, Djinane Spinosa
    Telles, Joao Paulo Mota
    NEUROLOGICAL SCIENCES, 2024, 45 (10) : 4679 - 4686
  • [30] Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia
    Davies, Simon J. C.
    Burhan, Amer M.
    Kim, Donna
    Gerretsen, Philip
    Graff-Guerrero, Ariel
    Woo, Vincent L.
    Kumar, Sanjeev
    Colman, Sarah
    Pollock, Bruce G.
    Mulsant, Benoit H.
    Rajji, Tarek K.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (05) : 509 - 523
12345